Get startedLog in
    Picture of Kyowa Kirin logo

    4151 — Kyowa Kirin News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: MEI Pharma And Kyowa Kirin Receive Orphan Drug Designation For Follicular Lymphoma Treatment

    Picture of Kyowa Kirin logoKyowa Kirin
    10/11/2021 14:23
    Nov 10 (Reuters) - Kyowa Kirin Co Ltd  4151.T :
    * MEI PHARMA AND KYOWA KIRIN RECEIVE ORPHAN DRUG DESIGNATION
FOR
ZANDELISIB FOR THE TREATMENT OF FOLLICULAR LYMPHOMA

Source text for Eikon:  ID:nBw95DzMZa 
Further company coverage:  4151.T 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Kyowa Kirin

    See all news